Structure-activity relationship and pharmacokinetic profile of 5-ketopyrazole factor Xa inhibitors.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2008-01-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2007.11.040PMID 18054227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, structure-activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors.

  2007cited by this paper
• Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.

  2007cited by this paper
• Aminobenzisoxazoles with biaryl P4 moieties as potent, selective, and orally bioavailable factor Xa inhibitors.

  2006cited by this paper
• 1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.

  2006cited by this paper
• Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor.

  2005cited by this paper
• New anticoagulants.

  2005cited by this paper
• Is a different effect on sympathetic nerve activity between nisoldipine and cilnidipine in humans?

  2004cited by this paper
• Discovery of 1-(2-aminomethylphenyl)-3-trifluoromethyl-N- [3-fluoro-2'-(aminosulfonyl)[1,1'-biphenyl)]-4-yl]-1H-pyrazole-5-carboxyamide (DPC602), a potent, selective, and orally bioavailable factor Xa inhibitor(1).

  2003cited by this paper
• Factor Xa inhibitors: today and beyond.

  2003cited by this paper
• Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants.

  2003cited by this paper
• Synthetic direct and indirect factor Xa inhibitors.

  2002cited by this paper
• Visions & Reflections Factor Xa - a promising target for drug development

  2002cited by this paper
• Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa.

  2001cited by this paper
• Mutagenicity studies of benzidine and its analogs: structure-activity relationships.

  2000cited by this paper
• A rationale for the non-mutagenicity of 2- and 3-aminobiphenyls.

  1989cited by this paper
• Activation of human prothrombin by highly purified human factors V and X-a in presence of human antithrombin.

  1975cited by this paper

• Microwave-assisted ionic liquid-mediated regioselective synthesis of 3-trifluoromethylpyrazoles: molecular docking, DFT, and biological studies

  2026cites this paper
• Bioinspired Synthesis of Bridged Isochromane Fused Pyrazoles by a Silver Catalyzed Cascade Reaction and Its Application for Antibacterial Activity

  2025cites this paper
• Palladium-Catalyzed Fluorinated Olefination of Aromatics.

  2024cites this paper
• Regiocontrolled Synthesis of 1-Substituted-3(5)-carboxyalkyl-1H-pyrazoles Using Trichloromethyl Enones

  2023cites this paper
• Synthesis of 3-Trifluoromethylpyrazole Derivatives

  2023cites this paper
• Design, synthesis and biological evaluation of novel pyrazole derivatives bearing sulfonamide scaffold as antiproliferative agents

  2023cites this paper
• A Direct Silver‐Catalyzed Three‐Component Approach to Trifluoromethylated Cyanopyrazoles and Cyanopyrazolines

  2023cites this paper
• Synthesis of trifluoromethyl or trifluoroacetyl substituted heterocyclic compounds from trifluoromethyl‐α,β‐ynones

  2022cites this paper
• Regioselective Synthesis of 5-Trifluoromethylpyrazoles by [3 + 2] Cycloaddition of Nitrile Imines and 2-Bromo-3,3,3-trifluoropropene.

  2021cites this paper
• Regioselective Synthesis of 4-Trifluoromethylpyrazoles from the Cycloaddition of Sulfonyl Hydrazones with 2-Chloro-2-trifluoromethylstyrenes

  2021cites this paper
• One‐Pot Two‐Step Synthesis of Isochromene‐Fused CF 3 ‐Substituted Pyrazoles

  2020cites this paper
• Regioselective Synthesis of 3-Trifluoromethylpyrazole by Coupling of Aldehydes, Sulfonyl Hydrazides, and 2-Bromo-3,3,3-trifluoropropene.

  2020cites this paper
• Cycloaddition of Trifluoroacetaldehyde N-Triftosylhydrazone (TFHZ-Tfs) with Alkynes for Synthesizing 3-Trifluoromethylpyrazoles.

  2020cites this paper
• Chemo- and regioselective reactions of 5-bromo enones/enaminones with pyrazoles.

  2019cites this paper
• Polysubstituted 3-trifluoromethylpyrazoles: regioselective (3 + 2)-cycloaddition of trifluoroacetonitrile imines with enol ethers and functional group transformations.

  2018cites this paper
• Inhibitors of the Growth‐Factor Activating Proteases Matriptase, Hepsin and HGFA: Strategies for Rational Drug Design and Optimization

  2018cites this paper
• Using a traceless directing group for the silver-mediated synthesis of 3-trifluoromethylpyrazoles: a computational study on the mechanism and origins of regioselectivity

  2018cites this paper
• Direct [3+2]-cycloaddition of electron-deficient alkynes with CF 3 CHN 2 : Regioselective one-pot synthesis of 3-trifluoromethylpyrazoles

  2017cites this paper
• Advances in Inhibitors of FXa.

  2015cites this paper
• Oxidative Cleavage of Furans

  2015cites this paper
• Regioselective cycloaddition of trifluorodiazoethane with electron-deficient allenic esters and ketones: access to CF3-substituted pyrazolines and pyrazoles.

  2014cites this paper
• Indoles synthesized from amines via copper catalysis.

  2013cites this paper
• Silver-mediated cycloaddition of alkynes with CF3CHN2: highly regioselective synthesis of 3-trifluoromethylpyrazoles.

  2013cites this paper
• Chapter Nine - Case History: Eliquis™ (Apixaban), a Potent and Selective Inhibitor of Coagulation Factor Xa for the Prevention and Treatment of Thrombotic Diseases

  2012cites this paper
• New one-pot, efficient, and regioselective method for the synthesis of 3-Trifluoromethyl-1H-1-phenylpyrazoles and alkyl 3-carboxylate analogs

  2012cites this paper
• Developments in factor Xa inhibitors for the treatment of thromboembolic disorders

  2011cites this paper
• Factor Xa inhibitors: next-generation antithrombotic agents.

  2010cites this paper
• Trifluoromethyl-substituted pyridyl- and pyrazolylboronic acids and esters: synthesis and Suzuki-Miyaura cross-coupling reactions.

  2009cites this paper
• Chapter 9 Recent Advances in Coagulation Serine Protease Inhibitors

  2009cites this paper
• Bis(enaminones) : Key Intermediates for Novel α,ω-Bis(pyrazolylphenoxy), Bis(pyranylphenoxy), and Bis(benzo[b]furanylphenoxy) Alkanes

  2009cites this paper
• Sulfonamidolactam inhibitors of coagulation factor Xa.

  2008cites this paper